MedPath

Maxillary Sinus Membrane Perforation Incidence During Osseodensification

Conditions
Sinus Floor Augmentation
Sinus Infection
Registration Number
NCT05954273
Lead Sponsor
Versah
Brief Summary

Measure the incidence of the maxillary sinus membrane perforation during the Osseodensification crestal sinus grafting procedure.

Detailed Description

Retrospective clinical study to :

1. Investigate maxillary sinus membrane perforation incidence via osseodensification crestal sinus grafting utilizing the Densah bur.

2. Assess the osseodensification technique efficacy for maxillary crestal sinus grafting with implant site preparation.

3. Study and analyze the maxillary sinus perforation rate during or post-Osseodensification-mediated sinus grafting as a function.

4. To share the knowledge from this retrospective analysis through scientific publications.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
500
Inclusion Criteria

1- Medically healthy patients treated with crestal sinus augmentation via osseodensification using the Densah Burs and implant placement.

Exclusion Criteria
  1. History of radiotherapy,
  2. Bisphosphonate medication.
  3. Active periodontal disease.
  4. Uncontrolled diabetes.
  5. Heavy smoking (> 20 cigarettes/day).
  6. Local acute apical abscess.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Maxillary sinus membrane perforation rate during osseodensification crestal sinus grafting procedure.During augmentation surgery

Measure the incidence of sinus membrane perforation during osseodensification

Secondary Outcome Measures
NameTimeMethod
Maxillary sinus augmentation levelDuring augmentation surgery

The height and width of augmentation level

Trial Locations

Locations (1)

Versah, LLC

πŸ‡ΊπŸ‡Έ

Jackson, Michigan, United States

Versah, LLC
πŸ‡ΊπŸ‡ΈJackson, Michigan, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.